Current and historical daily PE Ratio for Sino Biopharmaceutical Ltd (
HKSE:01177
) from 2003 to Apr 24 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Sino Biopharmaceutical stock (HKSE:01177) PE ratio as of Apr 24 2024 is 19.49.
More Details
Sino Biopharmaceutical Ltd (HKSE:01177) PE Ratio (TTM) Chart
Sino Biopharmaceutical Ltd (HKSE:01177) PE Ratio (TTM) Historical Data
View and export this data going back to 2003. Start your Free Trial
Total 1192
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Sino Biopharmaceutical PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-24 | 19.4 | 2024-02-19 | 22.5 |
| 2024-04-24 | 19.4 | 2024-02-16 | 22.8 |
| 2024-04-23 | 18.7 | 2024-02-15 | 21.4 |
| 2024-04-22 | 18.4 | 2024-02-14 | 21.2 |
| 2024-04-19 | 17.0 | 2024-02-09 | 21.1 |
| 2024-04-18 | 17.6 | 2024-02-08 | 21.7 |
| 2024-04-17 | 17.8 | 2024-02-07 | 21.7 |
| 2024-04-16 | 18.4 | 2024-02-06 | 21.5 |
| 2024-04-15 | 19.4 | 2024-02-05 | 20.1 |
| 2024-04-12 | 19.8 | 2024-02-02 | 20.6 |
| 2024-04-11 | 20.2 | 2024-02-01 | 21.1 |
| 2024-04-10 | 20.6 | 2024-01-31 | 20.4 |
| 2024-04-09 | 20.6 | 2024-01-30 | 20.8 |
| 2024-04-08 | 20.5 | 2024-01-29 | 21.3 |
| 2024-04-05 | 20.4 | 2024-01-26 | 20.9 |
| 2024-04-03 | 21.2 | 2024-01-25 | 21.3 |
| 2024-04-02 | 21.5 | 2024-01-24 | 21.2 |
| 2024-03-28 | 21.9 | 2024-01-23 | 21.6 |
| 2024-03-27 | 21.8 | 2024-01-22 | 20.7 |
| 2024-03-26 | 22.5 | 2024-01-19 | 21.2 |
| 2024-03-25 | 22.3 | 2024-01-18 | 22.0 |
| 2024-03-22 | 22.1 | 2024-01-17 | 21.1 |
| 2024-03-21 | 23.1 | 2024-01-16 | 21.8 |
| 2024-03-20 | 22.8 | 2024-01-15 | 22.6 |
| 2024-03-19 | 22.8 | 2024-01-12 | 23.3 |
| 2024-03-18 | 23.7 | 2024-01-11 | 24.1 |
| 2024-03-15 | 23.6 | 2024-01-10 | 24.5 |
| 2024-03-14 | 23.9 | 2024-01-09 | 24.1 |
| 2024-03-13 | 23.2 | 2024-01-08 | 23.5 |
| 2024-03-12 | 23.1 | 2024-01-05 | 24.0 |
| 2024-03-11 | 21.6 | 2024-01-04 | 24.4 |
| 2024-03-08 | 21.0 | 2024-01-03 | 24.2 |
| 2024-03-07 | 21.2 | 2024-01-02 | 24.3 |
| 2024-03-06 | 21.3 | 2023-12-29 | 25.1 |
| 2024-03-05 | 21.1 | 2023-12-28 | 24.6 |
| 2024-03-04 | 22.8 | 2023-12-27 | 30.6 |
| 2024-03-01 | 22.5 | 2023-12-22 | 29.6 |
| 2024-02-29 | 22.7 | 2023-12-21 | 29.2 |
| 2024-02-28 | 22.2 | 2023-12-20 | 29.5 |
| 2024-02-27 | 22.8 | 2023-12-19 | 29.2 |
| 2024-02-26 | 22.9 | 2023-12-18 | 30.6 |
| 2024-02-23 | 22.8 | 2023-12-15 | 32.4 |
| 2024-02-22 | 23.0 | 2023-12-14 | 31.8 |
| 2024-02-21 | 22.8 | 2023-12-13 | 31.1 |
| 2024-02-20 | 22.5 | 2023-12-12 | 31.0 |
Sino Biopharmaceutical Ltd (HKSE:01177) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Sino Biopharmaceutical Ltd
NAICS : 325412
ISIN : KYG8167W1380
Share Class Description:
HKSE:01177: Ordinary SharesCompare
Compare
Traded in other countries / regions
01177.Hong KongSMZ1.GermanySBMFF.USA IPO Date
2003-08-12Description
Sino Biopharmaceutical Co, or SBP, is one of the largest drugmakers in China, with CNY 27 billion revenue in 2021. Its four most important therapeutic areas are oncology, hepatitis, cardio-cerebral, and respiratory medicines. SBP's current portfolio is mostly generics, and some key drugs are facing severe price reductions. However, it also has a rich pipeline of early-to-market generics and biosimilars, especially in oncology and respiratory treatments.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers